The changing age distribution of prostate cancer in Canada

Canadian Journal of Public Health

Volumn 98, Issue 1, 2007, Pages 60-64

  Neutel, C Ineke ^a,b   Gao, Ru Nie ^a   Blood, Paul A ^c   Gaudette, Leslie A ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Age distribution; Incidence; Mortality; Prevalence; Prostate cancer

Indexed keywords

EID: 33846950814     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03405387     Document Type: Article

References (20)

1. Canadian Cancer Society/National Cancer Institute of Canada. Canadian Cancer Statistics 2005. Toronto, ON, 2005.
2. McDavid K, Lee J, Fulton JP, Tonita J, Thompson TD. Prostate cancer incidence and mortality rates and trends in the United States and Canada. Public Health Rep 2004;119:174-86.
3. Brawley OW. Prostate carcinoma incidence and patient mortality: The effects of screening and early detection. Cancer 1997;80:1857-63.
4. Cookson MM. Prostate cancer: Screening and early detection. Cancer Control 2001;8:133-40.
5. Feuer EJ, Mariotti A, Merrill R. Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates. Cancer 2002;95:870-80.
6. Hankey BF, Feuer EJ, Clegg LX, Hayes RB, Legler JM, Prorok PC, et al. Cancer surveillance series: Interpreting trends in prostate cancer - Part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J National Cancer Institute 1999;91:1017-24.
7. Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer (Pred Oncol) 2000;85:60-67.
8. Levy IG, Iscoe NA, Klotz LH. Prostate cancer: 1. The descriptive epidemiology in Canada. CMAJ 1998;159:509-13.
9. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer Statistics, 2001. Can Cancer J Clin 2001;51:15-36.
10. Merrill RM, Morris MK. Prevalence-corrected prostate cancer incidence rates and trends. Am J Epidemiol 2002;155:148-52.
11. Ellison LF, Gibbons L. Five-year relative survival from prostate, breast, colorectal and lung cancer. Health Rep 2001;13:23-34.
12. Ellison LF, Gibbons L. Leading cancers - changes in five-year relative survival. Health Rep 2004;15:19-32.
13. National Cancer Institute of Canada. Canadian Cancer Statistics 1995. Toronto: National Cancer Institute of Canada, 1995.
14. Coldman AJ, Phillips N, Pickles TA. Trends in prostate cancer incidence and mortality: An analysis of mortality change by screening intensity. CMAJ 2003;168:31-35.
15. Gibbons L, Waters C. Prostate cancer - testing, incidence, surgery and mortality. Health Rep 2003;14(3):9-20.
16. Holmberg L, Bill-Axelson A, Helgesen F, Salo JO, Folmerz P. Radical prostatectomy or watchful waiting in early prostate cancer? N Engl J Med 2002;347:781-89.
17. Holmberg L, Bill-Axelson A, Helgesen F, Salo JO, Fomerz P, Haggman M, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early cancer. N Engl J Med 2002;347:781-89.
18. Albertsen PC, Hanley JA, Gleason DF, Barry MJ. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 1998;280(11):975-80.
19. Albertsen PC, Walters S, Hanley JA. A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995. J Urol 2000;163(2):519-23.
20. Neutel CI, Gao R-N, Blood P, Gaudette LA. Trends in prostate cancer incidence, hospital utilization and surgical procedures, Canada, 1981-2000. Can J Public Health 2006;97(3):177-82.